References

Chen, C.J., H.I. Yang, J. Su, C. Jen and S. You et al., 2006. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. J. Am. Med. Assoc., 295: 65-73.
CrossRef  |  PubMed  |  Direct Link  |  

Chu, C.M. and Y.F. Liaw, 2005. Genotype C hepatitis B virus infection is associated with a higher risk of reactivation of hepatitis B and progression to cirrhosis than genotype B: A longitudinal study of hepatitis B e antigen-positive patients with normal aminotransferase levels at baseline. J. Hepatology, 43: 411-417.
CrossRef  |  PubMed  |  Direct Link  |  

Chu, C.M. and Y.F. Liaw, 2007. Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B. Gastroenterol., 133: 1458-1465.
CrossRef  |  PubMed  |  Direct Link  |  

El-Serag, H.B., 2012. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology, 142: 1264-1273.
CrossRef  |  Direct Link  |  

Fattovich, G., T. Stroffolini, I. Zagni and F. Donato, 2004. Hepatocellular carcinoma in cirrhosis: Incidence and risk factors. Gastroenterol., 127: 35-50.
PubMed  |  Direct Link  |  

Hossain, K.Z., N. Ahmad, S.M. Noor-e-Alam, M.J. Sarker and F.A. Khondoker et al., 2017. Correlation between HBeAg Status, HBV DNA, ALT, AST, GGT and liver histological activity in patients with chronic hepatitis B vrus infection. J. Clin. Exp. Hepatol., 7: 24-25.
Direct Link  |  

Li, Q., W. Li, C. Lu, Y. Huang and L. Chen, 2017. Serum hepatitis B surface antigen levels predict insignificant fibrosis and non-cirrhosis in hepatitis B e antigen positive patients with normal or mildly elevated alanine transaminase levels. Oncotarget, 8: 86463-86470.
CrossRef  |  PubMed  |  Direct Link  |  

Limdi, J.K. and G.M. Hyde, 2003. Evaluation of abnormal liver function tests. Postgrad. Med. J., 79: 307-312.
CrossRef  |  Direct Link  |  

Lin, C.W., C.C. Lin, L.R. Mo, C.Y. Chang and D.S. Perng et al., 2013. Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis. J. Hepatol., 58: 730-735.
CrossRef  |  PubMed  |  Direct Link  |  

Liu, Z. and J. Hou, 2006. Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Dual Infection. Int. J. Med. Sci., 3: 57-62.
PubMed  |  Direct Link  |  

Malinchoc, M., P.S. Kamath, F.D. Gordon, C.J. Peine and J. Rank et al., 2000. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatol., 31: 864-871.
CrossRef  |  PubMed  |  Direct Link  |  

Pan, C.Q. and J.X. Zhang, 2005. Natural history and clinical consequences of hepatitis B virus infection. Int. J. Med. Sci., 2: 36-40.
CrossRef  |  PubMed  |  Direct Link  |  

Rosenberg, W.M., M. Voelker, R. Thiel, M. Becka and A. Burt et al., 2004. Serum markers detect the presence of liver fibrosis: A cohort study. Gastroenterol., 127: 1704-1713.
PubMed  |  Direct Link  |  

Sarin, S.K., M. Kumar, G.K. Lau, Z. Abbas and H.L.Y. Chan et al., 2016. Asian-Pacific clinical practice guidelines on the management of hepatitis B: A 2015 update. Hepatol. Intl., 10: 1-98.
CrossRef  |  PubMed  |  Direct Link  |  

Shen, J., C.K. Huang, H. Yu, B. Shen and Y. Zhang et al., 2017. The role of exosomes in hepatitis, liver cirrhosis and hepatocellular carcinoma. J. Cell. Mol. Med., 21: 986-992.
CrossRef  |  Direct Link  |  

Trepo, C., H.L. Chan and A. Lok, 2014. Hepatitis B virus infection. Lancet, 384: 2053-2063.
CrossRef  |  PubMed  |  Direct Link  |